Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Multiplex Genotyping Developed for Rare Blood Types

By LabMedica International staff writers
Posted on 21 Mar 2013
A multiplex polymerase chain reaction combined with DNA pooling for mass screening has been developed for rare blood types.

All existing sequence-specific primers polymerase chain reaction (PCR-SSP) assays for blood typing, genotype one or several single-nucleotide polymorphisms (SNPs) individually, but DNA pooling is a way that reduces the amount of genotyping required.

Scientists at the Shanghai Blood Center (China) established a sensitive multiplex PCR-SSP assay testing pooled DNA to detect the rare Fyb and S alleles. It was applied to screen a total of 4,490 donor samples via testing of 898 DNA pools. The samples in the positive pools were further tested individually. Genomic DNA was extracted from ethylenediaminetetraacetate (EDTA) anticoagulated blood samples using the TIANamp Genomic DNA Kit (Tiangen Biotech; Beijing, China). Every five DNA samples of the 4,490 donors screened were pooled before the multiplex PCR.

Two hundred and fifty-four donors were tested positive for the Duffy Fyb allele, whereas 101 donors were positive for the S allele. Among the 254 Fy(b+) donors, five were Fy(a−b+) and 249 were Fy(a+b+). Among the 101 S+ donors, three were S+s− and 98 were S+s+. The rare Fyb and S alleles comprised 2.28% and 1.16%, respectively. The PCR-SSP assays were confirmed by sequencing analysis and serological testing.

The authors concluded that this genetic high-throughput screening provides a means of detecting relatively large numbers of donors while providing, to a certain extent, antigen-negative blood for “difficult” patients with rare antibodies. The multiplex PCR assay was combined with DNA pooling to reduce the number of tests required, making large-scale screening feasible, and a cost-effective strategy. The study was published on January 22, 2013, in the journal Transfusion Medicine.

Related Links:
Shanghai Blood Center
Tiangen Biotech


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.